Genes/signaling pathways | Role in gliogenesis | Role in GBM | Comments |
---|---|---|---|
TGF beta including BMP | Gliogenic. BMP works with SMAD in gliogensis | Inhibit G1 to S transitions and cause cytostasis. | Inhibit c-myc. BMP downregulates EGFR. |
PAX6 | Neurogenic but with Nkx6.1 it contributes to astrocytogenesis | Upregulated PAX6 acts as tumor suppressor | Controls VEGF, angiogenesis, and GBM invasiveness. |
P300 | Gliogenic, induces the cells more towards GFAP expression. | Anti-GBM. The c-myc gene overrides p300 and then GFAP, leading to upregulation of nestin | Repressor of nestin which is also involved with stemness (sox2). |
NRSF/REST | Astrocytogenic. It halts neurogenesis and induces gliogenesis. | Strong proliferative response makes it capable of contributing to GBM oncogenesis. | REST amplification is also implicated in GBM. Promotes stemness in GBM. |
LIF | Gliogenic. Low levels cause differentiation. | In GBM, TGF-beta signaling causes it to become pro-oncogenic. | When LIF is applied alone to cell lines, it causes growth inhibition in GBM. |
HOPX | Primarily astrocytogenic | Tumor suppressor. Downregulated in GBM | It keeps NSCs in quiescent stage. |
Notch | Contributes to gliogenesis but also contribute to the stemness in GBM | EGFR and Notch are interlinked and are upregulated in GBM. | NOTCH works with FGF to keep NSCs in proliferative stage. NPCs are regulated by notch signaling. |
SOX9 and SOX4 | Involved in gliogenesis but in GBM micro-environment lead to stemness. | Sox members are involved in reprogramming of GBM stem cells | Interacts with pathways Shh and Notch in morphogenesis. |
SHH | More neurogenic than oncogenic. | In GBM, shh upregulates Hes1 and is involved in stemness. | When PTEN becomes defective in GBM, then SHH and PI3K become dysregulated. |
FGFR | Gliogenic roles but in GBM development contribute to the oncogenesis. | FGFR has strong interactions with MAPK and in GBM become dysregulated | FGFR1 is expressed in neurons and FGFR2 is more expressed in gliogenic differentiation |
JAK-STAT | Gliogenic. It also contributes to the stem cell maintenance. | In GBM development, it becomes oncogenic. | Vast net of interactions. It interacts with PI3K/AKT/mTOR pathway, MAPK/ERK pathway and several others. |
STAT3 | Gliogenic. But micro-environment also has vast effect on its role. | In GBM, STAT3 mutations make massive contributions to GBM oncogenesis. | It also interacts with EGFR which plays key role in GBM development |
IL-6 family | Gliogenic. | Works with STAT3 in promoting pro-oncogenic pathways | With age, the gene expression of inflammatory cytokines increase in the body. |
G FAP and S100 | Involved in astrocytogenesis | Upregulated in GBM | GFAP also regulate astrocyte neuronal interactions |
Hey1 | Works with Notch in gliogenesis | Dysregulated Hes1 plays role in stemness and EMT induction in GBM development. | Shh also upregulates Hes1 gene expression |
NF-κB | When dysregulated, harms neural stem cells (NSCs) and gliogenesis potential. | In GBM oncogenesis, it contributes to EGFR amplification. | NF-κB in GBM also contributes to EMT and GBM stemness. |
Neuregulin-1 | It is a gene of EGF family and contributes to astrocytogenesis. | Nrg1 and erb interact with each other and in GBM contribute to oncogenesis. | Nrg1, TGF alpha, EGFR all have profound interactions with one another and impact PI3k/AKT pathway, MAPK and JAK/STAT pathway |
MAPK | Involved in gliogenesis. | In GBM, it interacts with EGFR, mTOR/PI3K/Akt, PDGFR, and RAS. | MAPK is also involved In Insulin resistance. |
MEK and E2F | Involved in gliogenesis but they contribute to G1 to S transitions in GBM development. | RAS over-expresses MEK in GBM. Rb1 interacts with CDKs in inhibiting E2F. | This pathway becomes damaged in GBM and CDKs cause E2F based G1 to S transitions. |
TCFL2/LEF | Involved in gliogenesis. | They have been detected in GBM samples. | These transcription factors of WNT signaling works with beta catenin. |
Ephrins and Netrins | Involved in gliogenesis. Their role also includes angiogenic activity. | Their dysregulations are involved in GBM development. | NTNs contribute to GBM stemness. NTN-1 activates Notch and interacts with EGFR. |
Transcription factors NFIX | NFIX TF interacts with STAT3 and is involved in gliogenesis. | NFIX works with Ezrin protein, both are dysregulated in GBM | TF NFIX regulates NPC differentiation. |